Retort Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.25 M
- Company Age 41 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.47 M
- Satisfied Charges ₹ 1.60 M
- Revenue Growth -26.47%
- Profit Growth -443.45%
- Ebitda -204.07%
- Net Worth -94.57%
- Total Assets 7.77%
About Retort Pharmaceuticals
Retort Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 1983 and has a history of 41 years and three months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹0.47 M. The company has closed loans amounting to ₹1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Varun Thakkar and Nandita Thakkar serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1983PTC010371
-
Company No.
010371
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 1983
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Retort Pharmaceuticals Private Limited offer?
Retort Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Capsules, Liver Supplement, Ayurvedic Liver Tonic, Ayurvedic Digestive Medicine, Ayurvedic Digestive Syrups, Ayurvedic Medicine, Leucorrhoea Herbal Capsule Tablet, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Diabetic Herbal Medicine.
Who are the key members and board of directors at Retort Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandita Thakkar
|
Director | 29-Apr-2021 | Current |
|
Varun Thakkar
|
Director | 23-Nov-2023 | Current |
Financial Performance of Retort Pharmaceuticals.
Retort Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.47% decrease. The company also saw a substantial fall in profitability, with a 443.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 94.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Retort Pharmaceuticals?
In 2021, Retort Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Viking Bulk Cargo Terminals Private LimitedVarun Thakkar is a mutual person
Charges (Loans)
₹0.47 M
₹1.60 M
Charges Breakdown by Lending Institutions
- Indian Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2009 | Indian Bank | ₹0.47 M | Open |
| 30 Aug 1995 | Andhra Bank | ₹1.60 M | Satisfied |
How Many Employees Work at Retort Pharmaceuticals?
Retort Pharmaceuticals has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Retort Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retort Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
